Spectrum begins Phase 2 Glioblastoma Multiforme study
The international, multicentre, randomised trial will evaluate the safety and efficacy of lucanthone administered in combination with temozolomide (TMZ) and radiation treatment. Spectrum Pharmaceuticals chairman, president and chief